The novel strategy to overcome the drug-resistant lung cancer: Dual targeting delivery of PROTAC to inhibit cancer-associated fibroblasts and lung cancer cells
- 18 October 2025
- journal article
- Published by Elsevier in Drug Resistance Updates
- Vol. 84, 101316
Abstract
No abstract availableKeywords
Funding Information
- Guangzhou Medical University (2025SRP003)
- Guangzhou Medical University (02\u2013410\u20132302068XM)
- National Key Research and Development Program of China (2022YFE0209700)
- Guangzhou Municipal Science and Technology Program key projects (2024A03J0891)
- Guangzhou Municipal Science and Technology Program key projects (SL2022A03J00613)
- Guangzhou Municipal Science and Technology Program key projects (202201011593)
- National Natural Science Foundation of China (32171312)
- National Natural Science Foundation of China (82072047)
This publication has 51 references indexed in Scilit:
- Targeting cancer-associated fibroblasts with hydroxyethyl starch nanomedicine boosts cancer therapyNano Research, 2023
- Targeting inorganic nanoparticles to tumors using biological membrane‐coated technologyMedcomm, 2022
- Engineered Bacterial Outer Membrane Vesicles as Controllable Two‐Way Adaptors to Activate Macrophage Phagocytosis for Improved Tumor ImmunotherapyAdvanced Materials, 2022
- Cancer-associated fibroblasts: An emerging target against esophageal squamous cell carcinomaCancer Letters, 2022
- A BRD4 PROTAC nanodrug for glioma therapy via the intervention of tumor cells proliferation, apoptosis and M2 macrophages polarizationActa Pharmaceutica Sinica B, 2022
- Susceptibility of Lung Carcinoma Cells to Nanostructured Lipid Carrier of ARV-825, a BRD4 Degrading Proteolysis Targeting ChimeraPharmaceutical Research, 2022
- Cancer-associated fibroblasts in non-small cell lung cancer: Recent advances and future perspectivesCancer Letters, 2021
- Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapyActa Biomaterialia, 2020
- MicroRNA-4651 targets bromodomain-containing protein 4 to inhibit non-small cell lung cancer cell progressionCancer Letters, 2020
- Erythrocyte–Platelet Hybrid Membrane Coating for Enhanced Nanoparticle FunctionalizationAdvanced Materials, 2017